Global Peripherally Acting Anti-Obesity Drug Industry Research & Trends Analysis Report
According to Latest Research by Market IntelliX, the global market for Peripherally Acting Anti-Obesity Drug should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Peripherally Acting Anti-Obesity Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Peripherally Acting Anti-Obesity Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Prescription Drugs segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital Pharmacies has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Peripherally Acting Anti-Obesity Drug include Novo Nordisk A/S, Pfizer Inc., Boehringer Ingelheim International GmbH, KVK Tech Inc., Gelesis Holdings, Vivus LLC., Currax Pharmaceuticals LLC, GlaxoSmithKline plc and CHEPLAPHARM Arzneimittel GmbH, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Peripherally Acting Anti-Obesity Drug. Report Highlights:
(1) Global Peripherally Acting Anti-Obesity Drug market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Peripherally Acting Anti-Obesity Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Peripherally Acting Anti-Obesity Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Peripherally Acting Anti-Obesity Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Peripherally Acting Anti-Obesity Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Peripherally Acting Anti-Obesity Drug, capacity, production and trends.
(7) Peripherally Acting Anti-Obesity Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Prescription Drugs
Non-prescription Drugs
Market segment by application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Novo Nordisk A/S
Pfizer Inc.
Boehringer Ingelheim International GmbH
KVK Tech Inc.
Gelesis Holdings
Vivus LLC.
Currax Pharmaceuticals LLC
GlaxoSmithKline plc
CHEPLAPHARM Arzneimittel GmbH
Rhythm Pharmaceuticals
1 Market Overview
1.1 Peripherally Acting Anti-Obesity Drug Definition
1.2 Global Peripherally Acting Anti-Obesity Drug Market Size and Forecast
1.2.1 By Revenue, Global Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
1.2.2 By Sales Volume, Global Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
1.2.3 Global Peripherally Acting Anti-Obesity Drug Price Trend, 2019-2030
1.3 China Peripherally Acting Anti-Obesity Drug Market Size and Forecast
1.3.1 By Revenue, China Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
1.3.2 By Sales Volume, China Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
1.3.3 China Peripherally Acting Anti-Obesity Drug Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Peripherally Acting Anti-Obesity Drug Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Peripherally Acting Anti-Obesity Drug Share in Global Market, 2019-2030
1.4.3 Peripherally Acting Anti-Obesity Drug Market Size: China VS Global, 2019-2030
1.5 Peripherally Acting Anti-Obesity Drug Market Dynamics
1.5.1 Peripherally Acting Anti-Obesity Drug Market Drivers
1.5.2 Peripherally Acting Anti-Obesity Drug Market Restraints
1.5.3 Peripherally Acting Anti-Obesity Drug Industry Trends
1.5.4 Peripherally Acting Anti-Obesity Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Peripherally Acting Anti-Obesity Drug Revenue by Company, 2019-2024
2.2 Global Peripherally Acting Anti-Obesity Drug Sales Volume by Company, 2019-2024
2.3 Global Peripherally Acting Anti-Obesity Drug Price by Company, 2019-2024
2.4 Global Peripherally Acting Anti-Obesity Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Peripherally Acting Anti-Obesity Drug Concentration Ratio
2.6 Global Peripherally Acting Anti-Obesity Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Peripherally Acting Anti-Obesity Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Peripherally Acting Anti-Obesity Drug Revenue by Company, 2019-2024
3.2 China Peripherally Acting Anti-Obesity Drug Sales Volume by Company, 2019-2024
3.3 China Peripherally Acting Anti-Obesity Drug Peripherally Acting Anti-Obesity Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Peripherally Acting Anti-Obesity Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Peripherally Acting Anti-Obesity Drug Domestic VS Export
3.6 China Market, Peripherally Acting Anti-Obesity Drug Import & Export
3.6.1 China Market, Peripherally Acting Anti-Obesity Drug Import & Export, 2019-2030
3.6.2 China Peripherally Acting Anti-Obesity Drug Import & Export Trends
3.6.3 Main Sources of China Peripherally Acting Anti-Obesity Drug Import
3.6.4 Export Destination of China Peripherally Acting Anti-Obesity Drug
4 Peripherally Acting Anti-Obesity Drug Production by Region
4.1 Global Peripherally Acting Anti-Obesity Drug Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Peripherally Acting Anti-Obesity Drug Manufacturers
4.3 Global Major Manufacturers, Peripherally Acting Anti-Obesity Drug Capacity Expansion and Future Plans
4.4 Global Peripherally Acting Anti-Obesity Drug Capacity by Region
4.5 Global Peripherally Acting Anti-Obesity Drug Production by Region
4.5.1 Global Peripherally Acting Anti-Obesity Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Peripherally Acting Anti-Obesity Drug Production by Region, 2019-2024
4.5.3 Global Peripherally Acting Anti-Obesity Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Peripherally Acting Anti-Obesity Drug Industry Chain
5.2 Peripherally Acting Anti-Obesity Drug Upstream Analysis
5.2.1 Peripherally Acting Anti-Obesity Drug Core Raw Materials
5.2.2 Main Manufacturers of Peripherally Acting Anti-Obesity Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Peripherally Acting Anti-Obesity Drug Production Mode
5.6 Peripherally Acting Anti-Obesity Drug Procurement Model
5.7 Peripherally Acting Anti-Obesity Drug Industry Sales Model and Sales Channels
5.7.1 Peripherally Acting Anti-Obesity Drug Sales Model
5.7.2 Peripherally Acting Anti-Obesity Drug Typical Distributors
6 Sights by Type
6.1 Peripherally Acting Anti-Obesity Drug Classification
6.1.1 Prescription Drugs
6.1.2 Non-prescription Drugs
6.2 By Type, Global Peripherally Acting Anti-Obesity Drug Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030
6.4 By Type, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030
6.5 By Type, Global Peripherally Acting Anti-Obesity Drug Price, 2019-2030
7 Sights by Application
7.1 Peripherally Acting Anti-Obesity Drug Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Peripherally Acting Anti-Obesity Drug Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030
7.4 By Application, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030
7.5 By Application, Global Peripherally Acting Anti-Obesity Drug Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Peripherally Acting Anti-Obesity Drug Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030
8.3 By Region, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Peripherally Acting Anti-Obesity Drug Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Peripherally Acting Anti-Obesity Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Peripherally Acting Anti-Obesity Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Peripherally Acting Anti-Obesity Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Peripherally Acting Anti-Obesity Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Peripherally Acting Anti-Obesity Drug Market Size Market Share
8.7 South America
8.7.1 South America Peripherally Acting Anti-Obesity Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Peripherally Acting Anti-Obesity Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Peripherally Acting Anti-Obesity Drug Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030
9.3 By Country, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.4.2 By Company, U.S. Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.4.3 By Type, U.S. Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.4.4 By Application, U.S. Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.5 Europe
9.5.1 Europe Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.5.2 By Company, Europe Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.5.3 By Type, Europe Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.5.4 By Application, Europe Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.6 China
9.6.1 China Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.6.2 By Company, China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.6.3 By Type, China Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.6.4 By Application, China Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.7.2 By Company, Japan Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.7.3 By Type, Japan Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.7.4 By Application, Japan Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.8.2 By Company, South Korea Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.8.3 By Type, South Korea Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.8.4 By Application, South Korea Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.9.3 By Type, Southeast Asia Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.9.4 By Application, Southeast Asia Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.10 India
9.10.1 India Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.10.2 By Company, India Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.10.3 By Type, India Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.10.4 By Application, India Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Peripherally Acting Anti-Obesity Drug Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024
9.11.3 By Type, Middle East & Asia Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
9.11.4 By Application, Middle East & Asia Peripherally Acting Anti-Obesity Drug Market Size, Share, 2024 VS 2030
10 Manufacturers Profile
10.1 Novo Nordisk A/S
10.1.1 Novo Nordisk A/S Company Information, Head Office, Market Area and Industry Position
10.1.2 Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.1.3 Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Novo Nordisk A/S Company Profile and Main Business
10.1.5 Novo Nordisk A/S Recent Developments
10.2 Pfizer Inc.
10.2.1 Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
10.2.2 Pfizer Inc. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.2.3 Pfizer Inc. Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Pfizer Inc. Company Profile and Main Business
10.2.5 Pfizer Inc. Recent Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.3.2 Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.3.3 Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.3.5 Boehringer Ingelheim International GmbH Recent Developments
10.4 KVK Tech Inc.
10.4.1 KVK Tech Inc. Company Information, Head Office, Market Area and Industry Position
10.4.2 KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.4.3 KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 KVK Tech Inc. Company Profile and Main Business
10.4.5 KVK Tech Inc. Recent Developments
10.5 Gelesis Holdings
10.5.1 Gelesis Holdings Company Information, Head Office, Market Area and Industry Position
10.5.2 Gelesis Holdings Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.5.3 Gelesis Holdings Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Gelesis Holdings Company Profile and Main Business
10.5.5 Gelesis Holdings Recent Developments
10.6 Vivus LLC.
10.6.1 Vivus LLC. Company Information, Head Office, Market Area and Industry Position
10.6.2 Vivus LLC. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.6.3 Vivus LLC. Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Vivus LLC. Company Profile and Main Business
10.6.5 Vivus LLC. Recent Developments
10.7 Currax Pharmaceuticals LLC
10.7.1 Currax Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position
10.7.2 Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.7.3 Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Currax Pharmaceuticals LLC Company Profile and Main Business
10.7.5 Currax Pharmaceuticals LLC Recent Developments
10.8 GlaxoSmithKline plc
10.8.1 GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
10.8.2 GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.8.3 GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 GlaxoSmithKline plc Company Profile and Main Business
10.8.5 GlaxoSmithKline plc Recent Developments
10.9 CHEPLAPHARM Arzneimittel GmbH
10.9.1 CHEPLAPHARM Arzneimittel GmbH Company Information, Head Office, Market Area and Industry Position
10.9.2 CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.9.3 CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 CHEPLAPHARM Arzneimittel GmbH Company Profile and Main Business
10.9.5 CHEPLAPHARM Arzneimittel GmbH Recent Developments
10.10 Rhythm Pharmaceuticals
10.10.1 Rhythm Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.10.2 Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
10.10.3 Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Rhythm Pharmaceuticals Company Profile and Main Business
10.10.5 Rhythm Pharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Peripherally Acting Anti-Obesity Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Peripherally Acting Anti-Obesity Drug Market Restraints
Table 3. Peripherally Acting Anti-Obesity Drug Market Trends
Table 4. Peripherally Acting Anti-Obesity Drug Industry Policy
Table 5. Global Peripherally Acting Anti-Obesity Drug Revenue by Company, 2019-2024, US$ million
Table 6. Global Peripherally Acting Anti-Obesity Drug Revenue Market Share by Company, 2019-2024
Table 7. Global Peripherally Acting Anti-Obesity Drug Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share by Company, 2019-2024
Table 9. Global Peripherally Acting Anti-Obesity Drug Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Peripherally Acting Anti-Obesity Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Peripherally Acting Anti-Obesity Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Peripherally Acting Anti-Obesity Drug Manufacturers Product Type
Table 13. China Peripherally Acting Anti-Obesity Drug Revenue by Company, 2019-2024, US$ million
Table 14. China Peripherally Acting Anti-Obesity Drug Revenue Market Share by Company, 2019-2024
Table 15. China Peripherally Acting Anti-Obesity Drug Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Peripherally Acting Anti-Obesity Drug Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Peripherally Acting Anti-Obesity Drug Import & Export Trends
Table 19. Main Sources of China Peripherally Acting Anti-Obesity Drug Import
Table 20. Export Destination of China Peripherally Acting Anti-Obesity Drug
Table 21. Global Headquarters and Manufacturing Base of Peripherally Acting Anti-Obesity Drug Manufacturers
Table 22. Global Major Manufacturers, Peripherally Acting Anti-Obesity Drug Capacity Expansion and Future Plans
Table 23. Global Peripherally Acting Anti-Obesity Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Peripherally Acting Anti-Obesity Drug Production by Region, 2019-2024, (K Units)
Table 25. Global Peripherally Acting Anti-Obesity Drug Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Peripherally Acting Anti-Obesity Drug Upstream (Raw Materials)
Table 27. Global Peripherally Acting Anti-Obesity Drug Typical Customers
Table 28. Peripherally Acting Anti-Obesity Drug Typical Distributors
Table 29. By Type, Global Peripherally Acting Anti-Obesity Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Peripherally Acting Anti-Obesity Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Peripherally Acting Anti-Obesity Drug Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Peripherally Acting Anti-Obesity Drug Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030
Table 37. By Country, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030
Table 39. Novo Nordisk A/S Company Information, Head Office, Market Area and Industry Position
Table 40. Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 41. Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Novo Nordisk A/S Company Profile and Main Business
Table 43. Novo Nordisk A/S Recent Developments
Table 44. Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
Table 45. Pfizer Inc. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 46. Pfizer Inc. Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Pfizer Inc. Company Profile and Main Business
Table 48. Pfizer Inc. Recent Developments
Table 49. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 50. Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 51. Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 53. Boehringer Ingelheim International GmbH Recent Developments
Table 54. KVK Tech Inc. Company Information, Head Office, Market Area and Industry Position
Table 55. KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 56. KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. KVK Tech Inc. Company Profile and Main Business
Table 58. KVK Tech Inc. Recent Developments
Table 59. Gelesis Holdings Company Information, Head Office, Market Area and Industry Position
Table 60. Gelesis Holdings Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 61. Gelesis Holdings Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Gelesis Holdings Company Profile and Main Business
Table 63. Gelesis Holdings Recent Developments
Table 64. Vivus LLC. Company Information, Head Office, Market Area and Industry Position
Table 65. Vivus LLC. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 66. Vivus LLC. Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Vivus LLC. Company Profile and Main Business
Table 68. Vivus LLC. Recent Developments
Table 69. Currax Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position
Table 70. Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 71. Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Currax Pharmaceuticals LLC Company Profile and Main Business
Table 73. Currax Pharmaceuticals LLC Recent Developments
Table 74. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
Table 75. GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 76. GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. GlaxoSmithKline plc Company Profile and Main Business
Table 78. GlaxoSmithKline plc Recent Developments
Table 79. CHEPLAPHARM Arzneimittel GmbH Company Information, Head Office, Market Area and Industry Position
Table 80. CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 81. CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. CHEPLAPHARM Arzneimittel GmbH Company Profile and Main Business
Table 83. CHEPLAPHARM Arzneimittel GmbH Recent Developments
Table 84. Rhythm Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 85. Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Models, Specifications and Application
Table 86. Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Rhythm Pharmaceuticals Company Profile and Main Business
Table 88. Rhythm Pharmaceuticals Recent Developments
List of Figure
Figure 1. Peripherally Acting Anti-Obesity Drug Picture
Figure 2. By Revenue, Global Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Peripherally Acting Anti-Obesity Drug Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Peripherally Acting Anti-Obesity Drug Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Peripherally Acting Anti-Obesity Drug Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Peripherally Acting Anti-Obesity Drug Share of Global Market, 2019-2030
Figure 10. Global Peripherally Acting Anti-Obesity Drug Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 11. Global Peripherally Acting Anti-Obesity Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2024
Figure 12. China Peripherally Acting Anti-Obesity Drug Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 13. China Peripherally Acting Anti-Obesity Drug Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 14. China Peripherally Acting Anti-Obesity Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Peripherally Acting Anti-Obesity Drug Domestic VS Export, 2024
Figure 16. Global Peripherally Acting Anti-Obesity Drug Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Peripherally Acting Anti-Obesity Drug Capacity Market Share by Region, 2024 VS 2030
Figure 18. Global Peripherally Acting Anti-Obesity Drug Production Market Share & Forecast by Region, 2019-2030
Figure 19. Peripherally Acting Anti-Obesity Drug Industry Chain
Figure 20. Peripherally Acting Anti-Obesity Drug Procurement Model
Figure 21. Peripherally Acting Anti-Obesity Drug Sales Model
Figure 22. Peripherally Acting Anti-Obesity Drug Sales Channels, Direct Sales and Distribution
Figure 23. Prescription Drugs
Figure 24. Non-prescription Drugs
Figure 25. By Type, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million
Figure 26. By Type, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030
Figure 27. By Type, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 28. By Type, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030
Figure 29. By Type, Global Peripherally Acting Anti-Obesity Drug Price, 2019-2030, (US$/Unit)
Figure 30. Hospital Pharmacies
Figure 31. Retail Pharmacies
Figure 32. Online Pharmacies
Figure 33. By Application, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million
Figure 34. By Application, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030
Figure 35. By Application, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 36. By Application, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030
Figure 37. By Application, Global Peripherally Acting Anti-Obesity Drug Price, 2019-2030, (US$/Unit)
Figure 38. By Region, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030
Figure 39. By Region, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030
Figure 40. North America Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, North America Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024
Figure 42. Europe Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, Europe Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024
Figure 44. Asia Pacific Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country/Region, Asia Pacific Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024
Figure 46. South America Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, South America Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024
Figure 48. Middle East & Africa Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. U.S. Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 50. By Company, U.S. Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 51. By Type, U.S. Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 52. By Application, U.S. Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 53. Europe Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, Europe Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 55. By Type, Europe Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 56. By Application, Europe Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 57. China Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, China Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 59. By Type, China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 60. By Application, China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 61. Japan Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, Japan Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 63. By Type, Japan Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 64. By Application, Japan Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 65. South Korea Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, South Korea Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 67. By Type, South Korea Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 68. By Application, South Korea Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 69. Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, Southeast Asia Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 71. By Type, Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 72. By Application, Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 73. India Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, India Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 75. By Type, India Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 76. By Application, India Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 77. Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, Middle East & Asia Peripherally Acting Anti-Obesity Drug Market Share, 2024
Figure 79. By Type, Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 80. By Application, Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|